Pharmacogenomics in diverse practice settings: Implementation beyond major metropolitan areas

Elizabeth H. Dorfman; Susan Brown Trinidad; Chelsea T. Morales; Kevin Howlett; Wylie Burke; Erica L. Woodahl

doi:10.2217/pgs.14.174

Pharmacogenomics in diverse practice settings: Implementation beyond major metropolitan areas

Elizabeth H. Dorfman, Susan Brown Trinidad, Chelsea T. Morales, Kevin Howlett, Wylie Burke, Erica L. Woodahl

Research output: Contribution to journal › Article › peer-review

23 Scopus citations

Abstract

Aim: The limited formal study of the clinical feasibility of implementing pharmacogenomic tests has thus far focused on providers at large medical centers in urban areas. Our research focuses on small metropolitan, rural and tribal practice settings. Materials & methods: We interviewed 17 healthcare providers in western Montana regarding pharmacogenomic testing. Results: Participants were optimistic about the potential of pharmacogenomic tests, but noted unique barriers in small and rural settings including cost, adherence, patient acceptability and testing timeframe. Participants in tribal settings identified heightened sensitivity to genetics and need for community leadership approval as additional considerations. Conclusion: Implementation differences in small metropolitan, rural and tribal communities may affect pharmacogenomic test adoption and utilization, potentially impacting many patients.

Original language	English
Pages (from-to)	227-237
Number of pages	11
Journal	Pharmacogenomics
Volume	16
Issue number	3
DOIs	https://doi.org/10.2217/pgs.14.174
State	Published - Mar 1 2015

Keywords

Alaska Native
American Indian
implementation
indigenous populations
pharmacogenetics
pharmacogenomics
rural

Access to Document

10.2217/pgs.14.174

Cite this

@article{f826ad720c614cea9965cbc5dbc8b595,

title = "Pharmacogenomics in diverse practice settings: Implementation beyond major metropolitan areas",

abstract = "Aim: The limited formal study of the clinical feasibility of implementing pharmacogenomic tests has thus far focused on providers at large medical centers in urban areas. Our research focuses on small metropolitan, rural and tribal practice settings. Materials & methods: We interviewed 17 healthcare providers in western Montana regarding pharmacogenomic testing. Results: Participants were optimistic about the potential of pharmacogenomic tests, but noted unique barriers in small and rural settings including cost, adherence, patient acceptability and testing timeframe. Participants in tribal settings identified heightened sensitivity to genetics and need for community leadership approval as additional considerations. Conclusion: Implementation differences in small metropolitan, rural and tribal communities may affect pharmacogenomic test adoption and utilization, potentially impacting many patients.",

keywords = "Alaska Native, American Indian, implementation, indigenous populations, pharmacogenetics, pharmacogenomics, rural",

author = "Dorfman, {Elizabeth H.} and {Brown Trinidad}, Susan and Morales, {Chelsea T.} and Kevin Howlett and Wylie Burke and Woodahl, {Erica L.}",

note = "Publisher Copyright: {\textcopyright} 2015 Future Medicine Ltd.",

year = "2015",

month = mar,

day = "1",

doi = "10.2217/pgs.14.174",

language = "English",

volume = "16",

pages = "227--237",

journal = "Pharmacogenomics",

issn = "1462-2416",

publisher = "Taylor and Francis Ltd.",

number = "3",

}

TY - JOUR

T1 - Pharmacogenomics in diverse practice settings

T2 - Implementation beyond major metropolitan areas

AU - Dorfman, Elizabeth H.

AU - Brown Trinidad, Susan

AU - Morales, Chelsea T.

AU - Howlett, Kevin

AU - Burke, Wylie

AU - Woodahl, Erica L.

PY - 2015/3/1

Y1 - 2015/3/1

N2 - Aim: The limited formal study of the clinical feasibility of implementing pharmacogenomic tests has thus far focused on providers at large medical centers in urban areas. Our research focuses on small metropolitan, rural and tribal practice settings. Materials & methods: We interviewed 17 healthcare providers in western Montana regarding pharmacogenomic testing. Results: Participants were optimistic about the potential of pharmacogenomic tests, but noted unique barriers in small and rural settings including cost, adherence, patient acceptability and testing timeframe. Participants in tribal settings identified heightened sensitivity to genetics and need for community leadership approval as additional considerations. Conclusion: Implementation differences in small metropolitan, rural and tribal communities may affect pharmacogenomic test adoption and utilization, potentially impacting many patients.

AB - Aim: The limited formal study of the clinical feasibility of implementing pharmacogenomic tests has thus far focused on providers at large medical centers in urban areas. Our research focuses on small metropolitan, rural and tribal practice settings. Materials & methods: We interviewed 17 healthcare providers in western Montana regarding pharmacogenomic testing. Results: Participants were optimistic about the potential of pharmacogenomic tests, but noted unique barriers in small and rural settings including cost, adherence, patient acceptability and testing timeframe. Participants in tribal settings identified heightened sensitivity to genetics and need for community leadership approval as additional considerations. Conclusion: Implementation differences in small metropolitan, rural and tribal communities may affect pharmacogenomic test adoption and utilization, potentially impacting many patients.

KW - Alaska Native

KW - American Indian

KW - implementation

KW - indigenous populations

KW - pharmacogenetics

KW - pharmacogenomics

KW - rural

UR - http://www.scopus.com/inward/record.url?scp=84923643202&partnerID=8YFLogxK

U2 - 10.2217/pgs.14.174

DO - 10.2217/pgs.14.174

M3 - Article

C2 - 25712186

AN - SCOPUS:84923643202

SN - 1462-2416

VL - 16

SP - 227

EP - 237

JO - Pharmacogenomics

JF - Pharmacogenomics

IS - 3

ER -

Pharmacogenomics in diverse practice settings: Implementation beyond major metropolitan areas

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this